Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation

Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, Lohitesh Kovooru, Francesca R. Noto, Grazia Pennisi, Salvatore Petta, Angela Mirarchi, Samantha Maurotti, Bernardette Scopacasa, Luca Tirinato, Patrizio Candeloro, Marcus Henricsson, Daniel Lindén, Oveis Jamialahmadi, Arturo Pujia, Rosellina M. Mancina, Stefano Romeo

Clin Mol Hepatol. 2025;31(2):445-459. Published online December 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0642

View: 2463 Download: 336 Crossref: 2

Letter to the Editor

Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”

Seung Min Lee, Dae Won Jun

Clin Mol Hepatol. 2023;29(1):171-172. Published online November 10, 2022

DOI: https://doi.org/10.3350/cmh.2022.0381

View: 3661 Download: 67

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Programmed cell death in alcohol-associated liver disease

Tatsunori Miyata, Laura E. Nagy

Clin Mol Hepatol. 2020;26(4):618-625. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0142

View: 12951 Download: 291 Web of Science: 62 Crossref: 67

Correspondence

Correspondence to editorial “Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma”

Yifei Qin, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu

Received April 11, 2025 Accepted April 24, 2025

DOI: https://doi.org/10.3350/cmh.2025.0402 [Accepted]

View: 235 Download: 17

1 |

Viewed By 10865	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7622	MAFLD: How is it different from NAFLD?
Viewed By 5512	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4961	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 4879	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 338	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 305	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 210	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 104	Non-alcoholic fatty liver disease: Definition and subtypes

Search